Drugs / sulphur hexafluoride lipid-type A microspheres
sulphur hexafluoride lipid-type A microspheres
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02282163 | Oct 2015 → May 2018 | heart disorder | Bracco Diagnostics, Inc | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sulphur hexafluoride lipid-type A microspheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02282163 ↗ |
| Modality | Diagnostic / imaging agent | “Ultrasound imaging contrast agent” NCT02282163 ↗ |